 |
Galmed Pharmaceuticals Ltd.
GLMD
|
4.31 M |
$ 4.63 |
21.05 % |
$ 20 M |
Israel |
 |
BioXcel Therapeutics
BTAI
|
12.2 M |
$ 0.07 |
9.81 % |
$ 855 K |
USA |
 |
Theravance Biopharma
TBPH
|
50.3 M |
$ 17.03 |
0.03 % |
$ 857 M |
Cayman-islands |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Forte Biosciences
FBRX
|
12.9 M |
$ 76.99 |
0.03 % |
$ 997 M |
USA |
 |
Aptose Biosciences
APTO
|
2.45 M |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Cleveland BioLabs, Inc.
CBLI
|
12.4 M |
- |
-7.31 % |
$ 49 M |
USA |
 |
Five Prime Therapeutics, Inc.
FPRX
|
36.8 M |
- |
- |
$ 1.77 B |
USA |
 |
Biofrontera AG
BFRA
|
27.8 M |
- |
-8.24 % |
$ 105 M |
Germany |
 |
Catabasis Pharmaceuticals, Inc.
CATB
|
19.4 M |
- |
-6.97 % |
$ 657 M |
USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
38.7 M |
- |
1.68 % |
$ 4.65 B |
China |
 |
Flexion Therapeutics, Inc.
FLXN
|
42.8 M |
- |
- |
$ 459 M |
USA |
 |
Heat Biologics, Inc.
HTBX
|
4.75 M |
- |
-5.76 % |
$ 99.8 M |
USA |
 |
Kindred Biosciences, Inc.
KIN
|
39.3 M |
- |
0.11 % |
$ 419 M |
USA |
 |
Shineco, Inc.
TYHT
|
2.95 M |
- |
-3.90 % |
$ 97.2 M |
China |
 |
Millendo Therapeutics, Inc.
MLND
|
1.27 M |
- |
-5.36 % |
$ 20.2 M |
USA |
 |
Intec Pharma Ltd
NTEC
|
3.95 M |
- |
-12.45 % |
$ 17.7 M |
Israel |
 |
Progenity, Inc.
PROG
|
49.3 M |
- |
-3.47 % |
$ 164 M |
USA |
 |
Strongbridge Biopharma plc
SBBP
|
56.1 M |
- |
1.52 % |
$ 136 M |
USA |
 |
Seneca Biopharma, Inc.
SNCA
|
366 K |
- |
-1.19 % |
$ 28.7 M |
USA |
 |
Celsion Corporation
CLSN
|
2.12 M |
- |
-6.63 % |
$ 13.9 M |
USA |
 |
I-Mab
IMAB
|
220 M |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
44.7 B |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
543 M |
- |
-13.47 % |
$ 169 M |
France |
 |
CureVac N.V.
CVAC
|
224 M |
- |
- |
$ 867 M |
Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
9.34 B |
- |
0.74 % |
$ 768 M |
Israel |
 |
Abcam plc
ABCM
|
229 M |
- |
- |
$ 4.9 B |
Britain |
 |
Midatech Pharma plc
MTP
|
54.9 B |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
MorphoSys AG
MOR
|
34.3 M |
- |
2.43 % |
$ 254 M |
Germany |
 |
Affimed N.V.
AFMD
|
120 M |
- |
-34.95 % |
$ 21.5 M |
Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
38.2 M |
- |
-1.58 % |
$ 28.1 M |
China |
 |
Celyad Oncology SA
CYAD
|
22.6 M |
- |
- |
$ 12.5 M |
Belgium |
 |
Gracell Biotechnologies
GRCL
|
338 M |
- |
- |
$ 3.37 B |
China |
 |
Galapagos NV
GLPG
|
65.9 M |
- |
- |
$ 1.83 B |
Belgium |
 |
Teligent, Inc.
TLGT
|
5.59 M |
- |
-13.85 % |
$ 16.1 M |
USA |
 |
Viela Bio, Inc.
VIE
|
12.3 M |
- |
- |
$ 2.91 B |
USA |
 |
Aphria Inc.
APHA
|
258 M |
- |
-0.45 % |
$ 4.87 B |
Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
42.1 M |
- |
-0.90 % |
$ 104 M |
USA |
 |
Chiasma, Inc.
CHMA
|
52.2 M |
- |
-6.00 % |
$ 238 M |
USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
27.7 M |
- |
- |
$ 376 M |
USA |
 |
Cellect Biotechnology Ltd.
APOP
|
213 M |
- |
0.38 % |
$ 12.9 M |
Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
28 M |
- |
2.07 % |
$ 34.4 M |
USA |
 |
Cerecor Inc.
CERC
|
73 M |
- |
-1.68 % |
$ 283 M |
USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
47.5 M |
- |
- |
$ 1.63 B |
USA |
 |
Auris Medical Holding Ltd.
EARS
|
2.91 M |
- |
-1.77 % |
$ 39.2 M |
Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
74.5 M |
- |
0.34 % |
$ 2.98 B |
USA |
 |
ERYTECH Pharma S.A.
ERYP
|
31 M |
- |
1.3 % |
$ 27.7 M |
France |
 |
GW Pharmaceuticals plc
GWPH
|
31.4 M |
- |
- |
$ 6.81 B |
Britain |